Efficacy, tolerability, and safety of non-pharmacological therapies for chronic pain: An umbrella review on various CAM approaches.

Posted on July 7, 2017 by David

“Complementary and alternative medicine (CAM) therapies may be used as a non-pharmacological approach to chronic pain management. Twenty-six reviews (207 clinical trials, >12,000 participants) about 18 CAM modalities, falling under natural products, mind and body practices or other complementary health approaches were included. Inhaled cannabis, graded motor imagery, and Compound Kushen injection (a form of Chinese medicine) were found the most efficient and tolerable for chronic pain relief. When reported, adverse effects related to these CAM were minor.” https://www.ncbi.nlm.nih.gov/pubmed/28669581

http://www.sciencedirect.com/science/article/pii/S0278584617300866

Inhaled cannabis for chronic neuropathic pain: an individual patient data meta-analysis.

Posted on September 13, 2015 by David

“Chronic neuropathic pain, the most frequent condition affecting the peripheral nervous system, remains under-diagnosed and difficult to treat.

Inhaled cannabis may alleviate chronic neuropathic pain.

Our objective was to synthesize the evidence on inhaled cannabis for chronic neuropathic pain.

This novel Bayesian individual patient data meta-analysis of five randomized trials suggests that inhaled cannabis may provide short term relief for one in five to six patients with neuropathic pain.

Pragmatic trials are need to evaluate the long-term benefits and risks of this treatment.”

http://www.ncbi.nlm.nih.gov/pubmed/26362106

Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.

Posted on May 17, 2015 by David

“Inflammatory bowel disease (IBD) patients suffer from significant morbidity and diminished life quality.

The plant cannabis is beneficial in various gastrointestinal diseases, stimulating appetite and causing weight gain.

Our aims were to assess whether treatment with inhaled cannabis improves quality of life, disease activity and promotes weight gain in these patients.

CONCLUSIONS:

Three months’ treatment with inhaled cannabis improves quality of life measurements, disease activity index, and causes weight gain and rise in BMI in long-standing IBD patients.”

http://www.ncbi.nlm.nih.gov/pubmed/22095142

http://www.thctotalhealthcare.com/category/inflammatory-bowel-disease-2/